Both Highlights Semaglutide and tirzepatide are both GLP-1 receptor agonists, but tirzepatide has a dual mechanism of action because it also stimulates GIP production
Semaglutide works by mimicking a hormone in the body called glucagon-like peptide-1 (GLP-1)
Fourth, although our data represent a diverse population, findings may best apply to the USA and have more limited applicability to international settings
Clinical Distinctions Faster onset of weight loss Greater reductions in waist circumference Modest improvements in lipids and blood pressure Potential cardiovascular benefit (awaiting full CVOT data) Tirzepatides dual mechanism appears to deliver greater efficacy without substantially worsening tolerability, though gastrointestinal side effects (nausea, vomiting, constipation) remain common at higher doses
Tranexamic acid is available from pharmacies for women aged 18-45 with regular heavy periods and can reduce menstrual blood loss by up to 50%
Rated 5 out of 5 Anonymous (verified owner) Incredible